Should We SPRINT Toward New Blood Pressure Goals or Let the Dust Settle?

American Journal of Medicine

Volumn 129, Issue 8, 2016, Pages 769-770

  Messerli, Franz H ^a,b,c   Bangalore, Sripal ^d  

^a UNIVERSITY OF BERN   (Switzerland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION;

EID: 84973570665     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2016.04.022     Document Type: Editorial

References (6)

1. 1 Group, S.R., Wright, J.T. Jr., Williamson, J.D., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:22 (2015), 2103–2116.
2. 2 Ortiz, E., James, P.A., Let's not SPRINT to judgment about new blood pressure goals. Ann Intern Med 164:10 (2016), 692–693.
3. 3 Fuster, V., Unraveling the complexities of statistical presentation: why it is important. J Am Coll Cardiol 66:25 (2015), 2909–2910.
4. 4 Lonn, E.M., Bosch, J., López-Jaramillo, P., et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med 374:21 (2016), 2009–2020.
5. 5 Brunstrom, M., Carlberg, B., Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ, 352, 2016, i717.
6. 6 Bangalore, S., Kumar, S., Lobach, I., Messerli, F.H., Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation 123:24 (2011), 2799–2810 9 pp following 810.